Expression of vascular endothelial growth factor and angiopoietins in human corpus cavernosum

BJU International

Volumn 105, Issue 2, 2010, Pages 269-273

  Tomada, Nuno ^a   Tomada, Inês ^b   Vendeira, Pedro ^a   Neves, Delminda ^b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Angiogenesis; Angiopoietins; Corpus cavernosum; Human; VEGF

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADOLESCENT; ADULT; ANGIOGENESIS; ARTICLE; CORPUS CAVERNOSUM; ENDOTHELIUM CELL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NORMAL HUMAN; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER;

ADOLESCENT; ADULT; ANGIOPOIETIN-1; ANGIOPOIETIN-2; HUMANS; IMMUNOBLOTTING; IMPOTENCE, VASCULOGENIC; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PENIS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 74049108571     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08663.x     Document Type: Article

References (38)

1. Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res 2005 66 : 286 294
2. Ylä-Herttula S, Markkanen JE, Rissanen TT. Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials. Trends Cardiovasc Med 2004 14 : 295 300
3. Freedman SB, Isner JM. Therapeutic angiogenesis for ischemic cardiovascular disease. J Mol Cell Cardiol 2001 33 : 379 393
4. Vajanto I, Rissanen TT, Rutanen J et al. Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenovirus vectors encoding VEGF and LacZ. J Gene Med 2002 4 : 371 380
5. Arsic N, Zentelin L, Zacchigna S et al. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol Ther 2003 7 : 450 459
6. Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R. Erectile dysfunction is a marker for cardiovascular disease: results of the Minority Health Institute Expert Advisory Panel. J Sex Med 2005 2 : 40 52
7. Guay A. ED2: erectile dysfunction = Endothelial dysfunction. Endocrinol Metab Clin N Am 2007 36 : 453 463
8. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ. Impaired brachial artery endothelium-dependent and - independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004 43 : 179 184
9. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nature Med 2003 9 : 669 676
10. Hood JD, Meininger CJ, Ziche M, Granger HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 1998 274 : H1054 8
11. van der Zee R, Murohara T, Luo Z et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997 95 : 1030 1037 (Pubitemid 27091550)
12. Sadoun E, Reed MJ. Impaired angiogenesis in aging is associated with alterations in vessel density, matrix composition, inflammatory response, and growth factor expression. J Hystochem Cytochem 2003 51 : 1119 1130
13. Ryu J, Shin H, Song S et al. Downregulation of angiogenic factors and their downstream target molecules affects the deterioration of erectile function in a rat model of hypercholesterolemia. Urology 2006 31 : 401 418
14. Rogers RS, Graziottin TM, Lin CS, Lue TF. Intracavernosal vascular endothelial factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res 2003 15 : 26 37
15. Lee MC, El-Sakka AI, Graziottin TM, Ho HC, Lin CS, Lue TF. The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction. J Urol 2002 167 : 761 767
16. Gholami SS, Rogers R, Chang J et al. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J Urol 2003 169 : 1577 1581
17. Dall'Era JE, Meacham RB, Mills JN et al. Vascular endothelial growth factor (VEGF) gene therapy using a nonviral gene delivery system improves erectile function in a diabetic rat model. Int J Impot Res 2008 20 : 307 314
18. Pettersson A, Nagy JA, Brown LF et al. Heterogeneity of angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 2000 80 : 99 115
19. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000 102 : 898 901
20. Chae JK, Kim I, Lim ST et al. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 2000 20 : 2573 2578
21. Ryu JK, Cho CH, Shin HY et al. Combined angiopoietin-1 and vascular endothelial growth factor gene transfer restores cavernous angiogenesis and erectile function in a rat model of hypercholesterolemia. Mol Ther 2006 13 : 705 715
22. Davis S, Aldrich TH, Jones PF et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996 87 : 1161 1169 (Pubitemid 27010100)
23. Maisonpierre PC, Suri C, Jones PF et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997 277 : 55 60
24. Suri C, Jones PF, Patan S et al. Requisite role of angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis. Cell 1996 87 : 1171 1180
25. Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 1999 18 : 5356 5362
26. Stratmann A, Risau W, Plate RH. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 1998 153 : 1459 1466
27. Carmeliet P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nature Med 2000 6 : 1102 1103
28. Shyu KG, Chang H, Isner JM. Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia. Life Sci 2003 73 : 563 579
29. Visconti RP, Richardson CD, Sato TN. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci 2002 99 : 8219 8224
30. Oliveira R, Tomada N, Tomada I, Neves D, Vendeira P. Transmission electron microscopy comparative study between normal human corpus cavernosum and an induced male hypogonadism model. J Sex Med 2008 5 (Suppl. 2 96
31. Burchardt M, Burchardt T, Chen MW et al. Expression of messenger ribonucleic acid splice variants for vascular endothelial growth factor in the penis of adult rats and humans. Biol Reprod 1999 60 : 398 404
32. Neves D, Santos J, Tomada N, Almeida H, Vendeira P. Aging and orchidectomy modulate expression of VEGF receptors (Flt-1 and Flk-1) on corpus cavernosum of the rat. Ann N Y Acad Sci 2006 1067 : 164 172
33. Rajasekaran M, Kasyan A, Allilain W, Monga M. Ex vivo expression of angiogenic growth factors and their receptors in human penile cavernosal cells. J Androl 2003 24 : 85 90
34. Feng D, Nagy JA, Brekken RA et al. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem 2000 48 : 545 556
35. Batard P, Sansilvestri P, Scheinecker C et al. The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. Blood 1996 87 : 2212 2220
36. Fiedler U, Scharpfenecker M, Koidl S et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004 103 : 4150 6
37. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999 274 : 15732 15739
38. Mandriota SJ, Pyke C, Di Sanza C, Quinodoz P, Pittet B, Pepper MS. Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia. Am J Pathol 2000 156 : 2077 2089